Form D · Biotechnology
Ne Plus Corp
Flushing, NY · CIK 0001793317
Offering snapshot reported Nov 12, 2019 · SEC filing
- Reported sold
- $1.46M Offering amount: $5M
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $3K Reported outside-investor minimum
- First sale
- Nov 1, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2019 | Initial | $1,461,000 | No comparison | 35 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-353065
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Nov 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Wong | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
136 33 37th Ave 9 B
Flushing, NY, 11354
Flushing, NY, 11354